Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Infectious Diseases and Therapy
|
May 21, 2025
The Potential Impact of Increased Recombinant Zoster Vaccine Uptake in Older Adults Worldwide
Nikolaos Giannelos, Desmond Curran, Sean Matthews, et al.
The Journal of Infectious Diseases
|
December 7, 2023
The Annual Economic Burden of Respiratory Syncytial Virus in Adults in the United States
Justin Carrico, Katherine A Hicks, Eleanor Wilson, et al.
Pharmacoeconomics - Open
|
March 29, 2020
The Budget Impact of Introducing Tildrakizumab to a United States Health Plan for Managing Moderate-to-Severe Plaque Psoriasis
Justin Carrico, Yang Zhao, Xiaoying Jia, et al.
Vaccine
|
December 17, 2025
Herpes zoster vaccination among immunocompromised adults in the United States
Justin Carrico, Catherine McGuiness, Marie Yasuda, et al.
BMC Health Services Research
|
April 25, 2025
Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada
Sydney George, Justin Carrico, Katherine A Hicks, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 24, 2025
Herpes zoster vaccine uptake following provider prescription among older adults in the United States
Justin Carrico, Yong Zhu, Lisa Le, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 26, 2026
Risk of herpes zoster among adults in the United States initiating immunosuppressive therapy: A retrospective cohort study
Justin Carrico, Yong Zhu, Andrea Steffens, et al.
Pharmacoeconomics - Open
|
April 11, 2024
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older
Sydney George, Justin Carrico, Katherine A Hicks, et al.
Human Vaccines & Immunotherapeutics
|
April 1, 2022
Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccination
Jean-Etienne Poirrier, Jessica K DeMartino, Saurabh Nagar, et al.
Journal of American College Health : J of ACH
|
January 26, 2023
Estimating the cost of university-based outbreaks of serogroup B meningococcal disease with different pre-matriculation vaccination policies in the United States
Katherine A Hicks, Parinaz Ghaswalla, Justin Carrico, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Infectious Diseases and Therapy
|
May 21, 2025
The Potential Impact of Increased Recombinant Zoster Vaccine Uptake in Older Adults Worldwide
Nikolaos Giannelos, Desmond Curran, Sean Matthews, et al.
The Journal of Infectious Diseases
|
December 7, 2023
The Annual Economic Burden of Respiratory Syncytial Virus in Adults in the United States
Justin Carrico, Katherine A Hicks, Eleanor Wilson, et al.
Pharmacoeconomics - Open
|
March 29, 2020
The Budget Impact of Introducing Tildrakizumab to a United States Health Plan for Managing Moderate-to-Severe Plaque Psoriasis
Justin Carrico, Yang Zhao, Xiaoying Jia, et al.
Vaccine
|
December 17, 2025
Herpes zoster vaccination among immunocompromised adults in the United States
Justin Carrico, Catherine McGuiness, Marie Yasuda, et al.
BMC Health Services Research
|
April 25, 2025
Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada
Sydney George, Justin Carrico, Katherine A Hicks, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 24, 2025
Herpes zoster vaccine uptake following provider prescription among older adults in the United States
Justin Carrico, Yong Zhu, Lisa Le, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 26, 2026
Risk of herpes zoster among adults in the United States initiating immunosuppressive therapy: A retrospective cohort study
Justin Carrico, Yong Zhu, Andrea Steffens, et al.
Pharmacoeconomics - Open
|
April 11, 2024
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older
Sydney George, Justin Carrico, Katherine A Hicks, et al.
Human Vaccines & Immunotherapeutics
|
April 1, 2022
Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccination
Jean-Etienne Poirrier, Jessica K DeMartino, Saurabh Nagar, et al.
Journal of American College Health : J of ACH
|
January 26, 2023
Estimating the cost of university-based outbreaks of serogroup B meningococcal disease with different pre-matriculation vaccination policies in the United States
Katherine A Hicks, Parinaz Ghaswalla, Justin Carrico, et al.
Page
of 4